Skip to main content

Table 4 Feasibility & adequacy of core biopsy procedures

From: A pilot study to assess the feasibility of evaluation of markers of response to chemotherapy at one day & 21 days after first cycle of chemotherapy in carcinoma of breast: a prospective non-randomized observational study

Procedure

N

%

Core biopsy at baseline (C0 biopsy)

30

100

Core biopsy 24–48 hours after first cycle of chemotherapy (C1 biopsy)

30

100

Core biopsy 21 days after first cycle of chemotherapy (C2 biopsy)

26

86.6

Adequacy

  

At C0 biopsy

30

100

At C1 biopsy

28

93.3

At C2 biopsy

22

73.3 (84.3% of 26 attempted)

4 (13.3%) refused C2 biopsy; 4 (13.3%) had paucicellular harvest on C2 biopsy

Definitive surgery

26

86.6

4 (13.3%) patients did not undergo surgery due to different reasons.